Suzhou, Jiangsu, China Related Funds
| Fund Name | Location |
| Ambrum Capital | China, Guangdong, Shenzhen |
| Athaal Group | Jeddah, Makkah, Saudi Arabia |
| Changshang Kunzhong | - |
| Como Venture | Como, Italy, Lombardia |
| Czar Capital | England, London, United Kingdom |
| Dear Life | Japan, Tokyo |
| Department for Business, Energy and Industrial Strategy | England, London, United Kingdom |
| DHV partners | - |
| East Pacific Capital Private Limited | Central, Central Region, Singapore |
| Emma Group | England, London, United Kingdom |
| Everbright ZTE | Beijing, Beijing, China |
| Novabase Capital | Lisboa, Lisbon, Portugal |
| Nsfocus Information Technology Co. | Beijing, Beijing, China |
| NTT Finance | Japan, Tokyo |
| Ricoh Ventures | California, Cupertino, United States |
| Shenshahai Chuangye Touzi | Chengguan District, China, Lhasa |
| Sud Partners | France, Lyon, Rhone-Alpes |
| TDI Ventures, LLC | - |
| TMI Investments BV | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vision Pharmaceutical | $15M | 28 Dec 2021 | Wuhan, Hubei, China | ||
| $463K | 10 Aug 2017 | China, Zhangjiagang | |||
NAVSTON | $1M | 29 Jul 2015 | Zhangjiagang, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vision Pharmaceutical | $15M | 28 Dec 2021 | Wuhan, Hubei, China | ||
| $463K | 10 Aug 2017 | China, Zhangjiagang | |||
NAVSTON | $1M | 29 Jul 2015 | Zhangjiagang, Jiangsu, China |
